Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systolic hypertension.

David T Nash1

  • 1SUNY Upstate Medical University, Syracuse Preventive Cardiology Center, Syracuse, NY, USA.

Geriatrics
|December 23, 2006
PubMed
Summary
This summary is machine-generated.

Managing systolic hypertension is crucial for reducing cardiovascular mortality and stroke in older adults. Combination therapy, particularly with calcium-channel blockers and ACE inhibitors, shows promise for effective blood pressure control and improved tolerability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gluten sensitivity: new epidemic or new myth?

Proceedings (Baylor University. Medical Center)·2014
Same author

Gluten sensitivity: new epidemic or new myth? Every major change in our diet carries with it the possibility of unforeseen risks.

The American journal of cardiology·2014
Same author

Translating current knowledge into dementia prevention.

Alzheimer disease and associated disorders·2012
Same author

Time for a 6-minute walk?

Archives of internal medicine·2012
Same author

Valsartan combination therapy in the management of hypertension - patient perspectives and clinical utility.

Integrated blood pressure control·2011
Same author

Nutritional and exercise aspects of cognitive impairment.

Journal of clinical lipidology·2011
Same journal

A new method of local treatment of rheumatoid and traumatic affections of the joints.

Geriatrics·2010
Same journal

Cardiovascular deterioration.

Geriatrics·2010
Same journal

Some prophylactic suggestions regarding the science of geriatrics.

Geriatrics·2010
Same journal

The senile and prematurely senile skin.

Geriatrics·2010
Same journal

Guillain-Barré's disease in the older age group.

Geriatrics·2010
Same journal

Pancreatitis in geriatric practice.

Geriatrics·2010
See all related articles

Area of Science:

  • Cardiology
  • Geriatrics
  • Pharmacology

Background:

  • Hypertension affects one-third of adults, with systolic hypertension being a significant concern in older populations.
  • Despite proven benefits, controlling systolic blood pressure remains a challenge in clinical practice.
  • Elevated systolic blood pressure is a major cardiovascular risk factor, contributing to mortality and stroke.

Purpose of the Study:

  • To review systolic blood pressure as a cardiovascular risk factor.
  • To discuss effective management strategies for elevated systolic blood pressure.
  • To emphasize the role of combination therapy in managing hypertension.

Main Methods:

  • Review of large-scale clinical trials and scientific literature.
  • Analysis of systolic blood pressure as a cardiovascular risk factor.

Related Experiment Videos

  • Evaluation of combination therapy, specifically calcium-channel blockers and ACE inhibitors.

    • Main Results:

    • Treatment of isolated systolic and systolic/diastolic hypertension reduces mortality and stroke rates in older adults.
    • Combination therapy with calcium-channel blockers and ACE inhibitors demonstrates blood pressure-lowering efficacy.
    • This combination may offer additional benefits in tolerability and cognitive function.

    Conclusions:

    • Effective management of elevated systolic blood pressure is essential for cardiovascular health in older adults.
    • Combination therapy, particularly with calcium-channel blockers and ACE inhibitors, is a key strategy for improving blood pressure control.
    • Metabolically neutral agents in combination may enhance patient outcomes beyond blood pressure reduction.